Archive


Category: diabetes

  • Health Innovators: Senseonics’ Francine Kaufman

    In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics. Francine Kaufman discusses how Senseonics is helping patients monitor their diabetes with the first fully implantable long-term continuous glucose monitoring (CGM) system. Monitoring glucose values is necessary for diabetes patients, and technologically […]

  • Novo Nordisk on seeking partnerships to expand its portfolio

    Its vast experience in diabetes and the amount of data collected has propelled Novo Nordisk into exploring new modalities and searching for valuable collaborators, according to the company’s senior VP of global drug discovery Karin Conde-Knape. She discusses which therapeutic areas the company is gaining momentum in and how it aims to build its presence […]

  • Viatris and Biocon Launch Semglee (insulin glargine-yfgn) and Insulin Glargine (insulin glargine-yfgn) for the Treatment of Diabetes in the US

    Shots: The companies launch Semglee and Insulin Glargine as interchangeable biosimilars products to improve patients’ access with type 1 & 2 diabetes. Biocon and Viatris have co-developed both biosimilars products Both biosimilars products are available in a vial and prefilled pen presentations & will allow pharmacy level substitution for the reference product, Lantus across the […]

  • Poor Glycaemic Control and Tooth Loss Study

    (World Diabetes Day, 14 November 2021) Largest tooth loss research study finds poor glycemic control in the over 30s results in fewer teeth In the largest study of its kind, 233,567 individuals’ insurance claims & check up data was analyzed to assess the relationship between glycemic control and natural tooth retention by age group The […]

  • U of Florida to Deploy DreaMed AI Solution for Type 2 Diabetes

    What You Should Know: – DreaMed Diabetes AI, developer of the AI-powered Advisor Pro Clinical Decision Support System and expert-care platform for diabetes, announced today the expansion of its commercial relationship with the Pediatric Endocrinology Clinic at the University of Florida in Gainesville. – The clinic will begin using the Advisor Pro Decision-Support System for […]

  • Digital health firm Better Therapeutics makes Nasdaq debut

    Better Therapeutics has joined the ranks of publicly-listed digital health companies after completing a merger with blank cheque company Mountain Crest Acquisition Corp II. The company, which specialises in prescription digital therapeutics (DTx) for cardiometabolic diseases, listed on the Nasdaq under the BTTX ticker late on Friday. Shares initially fell back slightly from an opening […]

  • Is Ro taking the business-to-business route next?

    By all accounts, Ro is a successful direct-to-consumer telehealth and pharmacy services startup. At the recently-concluded HLTH conference, Ro’s chief medical officer speculated on how it might enter the business-to-business healthcare world.

  • Twin Health raises $140m for “digital twin” diabetes reversal app

    The developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $140 million in funding to develop the technology. US and India-based Twin Health says the Whole Body Digital Twin platform uses Internet of Things (IoT) […]

  • ViewPoints Interview: Zealand Pharma’s Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

    In an interview with PharmaShots, Dr. David Kendall, Senior Global Medical Advisor at Zealand Pharma shares insight on the availability of Zegalogue in the US for severe hypoglycemia in pediatric and adult patients with diabetes & its availability in both an auto-injector and a prefilled syringe Shots: The company reported the availability of Zegalogue (0.6mg/0.6mL) […]

  • 9am.health Launches Virtual Diabetes Clinic, Raises $3.7M

    What You Should Know: –  9am.health, a new San Diego, CA-based virtual diabetes clinic delivering personalized, affordable and kind care directly to consumers, today announced the launch of its unique virtual care platform, which provides comprehensive, affordable and compassionate care to people living with prediabetes or type 2 diabetes. In addition, the company also announced […]

  • Does Coconut Oil Help with Abdominal Fat?

    What does a review of the evidence on the effects of coconut oil on weight loss and belly fat find?  I begin my video Flashback Friday: Coconut Oil and Abdominal Fat with a popular infographic that surprised me by showing that, evidently, there is promising evidence that coconut oil could help with obesity. Well, if you fill the stomachs of rats with purified medium-chain fatty acids, one component of coconut oil, they end […]

  • India’s Breathe Well-being raises $5.5m for diabetes reversal app

    Digital health startup Breathe Well-being has raised $5.5 million in first-round financing, which it will use to scale up its clinical tool that it says helps people “prevent, manage and reverse type 2 diabetes.”  The Series A – led by US venture capital group Accel with participation from General Catalyst and Scott Shleifer, global managing […]

  • Headed Away to School? Here’s What Students With Health Issues Need to Know

    College is a time of transition, but for those managing chronic medical conditions, it may also be the first time they will be wholly responsible for their own health: setting appointments, securing supplies and pharmaceuticals, and monitoring symptoms. For those heading to schools far from home, it can be especially tricky navigating the complex world […]

  • New Approaches and Evolutions to Reshape the Diabetes Management and Care

    As per the WHO, “the number of people affected with Diabetes has grown significantly from 108 million in 1980 to 422 million in 2014. A rising trend in prevalence is observed in low- and middle-income countries as compared to high-income countries”. Additionally, Diabetes is a significant cause of the number of deaths worldwide, in 2019, […]

  • Diabetes Drug’s New Weight Loss Formula Fuels Cost-Benefit Debate

    The long list of side effects that follow ads for the newer expensive drugs to treat Type 2 diabetes sometimes include an unusual warning: They might cause weight loss. That side effect is one that many people — especially those with Type 2 diabetes, which is associated with obesity — may desperately want. So it’s […]

  • Research institute green-lights $254M for 28 studies 

    The Patient-Centered Outcomes Research Institute has awarded the funds to studies that span a range of healthcare issues, including maternal care, suicide prevention and clinical effectiveness research in arenas like telemedicine and diabetes.

  • Viatris and Biocon’s Semglee (biosimilar, insulin glargine) Receive the US FDA’s Approval as the First Interchangeable Biosimilar for Diabetes

    Shots: The US FDA has approved Semglee (insulin glargine-yfgn injection) as the first interchangeable biosimilar product under the 351(k) regulatory pathways to treat diabetes Semglee will allow pharmacy level substitution for the reference product, Lantus across the US & will be launch before the end of 2021. Biocon is eligible to have exclusivity for 12mos. […]

  • Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help

    Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a stronger, more resilient health care system is apparent in light of new data from the U.S. Centers for Disease Control and Prevention that show an increasing number of deaths from […]

  • Lilly grabs glucose-sensing insulin tech, buying Protomer in $1bn deal

    Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright.  Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only […]

  • Bayer’s finerenone gets FDA nod for diabetic kidney disease

    Bayer’s big investment in time and money on the development of finerenone for chronic kidney disease (CKD) in diabetics has paid off with an FDA approval, although it could face stiff competition in the market.  The oral, non-steroidal mineralocorticoid receptor (MR) antagonist has been approved as Kerendia in the US – its first world market […]

  • FDA rejects Provention’s type 1 diabetes drug teplizumab

    The FDA indicated something was not well with Provention Bio’s filing for type 1 diabetes therapy teplizumab in April when it delayed its review. Now, the agency has rejected the application entirely, sending the company’s shares into a steep slide. The complete response letter (CRL) for teplizumab as a treatment to delay clinical type 1 […]

  • Carbon Health buys virtual diabetes clinic firm Steady Health

    US healthcare group Carbon Health has made a move into digital care for patients with chronic conditions, buying diabetes-focused startup Steady Health. Steady Health has developed a platform that combines a continuous glucose monitoring (CGM) device with real-time, online coaching from endocrinologists, with the objective of improving management of diabetes and reducing the risk of […]

  • Helen Murray Free obituary

    Chemist who transformed medical screening by developing glucose dipsticks In the 1950s the US chemist Helen Murray Free, who has died aged 98, was responsible for developing glucose dipsticks. Their use led to much simpler medical screening methods that are still widely used today for pregnancy tests, the diagnosis and monitoring of diabetes, and to […]

  • The US FDA’s EMDAC Supports Provention Bio’s Teplizumab in Delaying Diabetes

    Shots: EMDAC has voted 10-7, confirming that the benefits of teplizumab outweigh the risks supporting the approval to delay T1D Mellitus The recommendation is based on a pivotal TN-10 study in which a single 14-day course of teplizumab delayed insulin-dependent, clinical-stage disease by a median of at least 2yrs. in pre symptomatic patients with stage […]

  • Trial win sets up filings for Lilly’s diabetes blockbuster hope tirzepatide

    Eli Lilly has scored five out of five with its phase 3 trials of type 2 diabetes candidate tirzepatide, setting up regulatory filings for a drug that the drugmaker thinks could be the lynchpin of its franchise in the coming years.  In SURPASS-4 – the last of Lilly’s registration studies for the dual GLP-1/GIP agonist […]

  • Eli Lilly looks ahead to FDA after diabetes drug wraps up last clinical test

    Eli Lilly diabetes drug tirzepatide beat long-acting insulin in the last of a series of global studies designed to support regulatory submissions for the type 2 diabetes drug, a potential successor to blockbuster drug Trulicity. The Indianapolis-based drug giant said it expects to file for approval by the end of 2021.

  • Arecor hopes London stock market float will raise profile of insulin products

    UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. Based in Cambridge, Arecor has proprietary formulation technology and plans to licence out drugs to big pharma companies, looking for milestone payments and royalties as […]

  • The Most Antioxidant-Packed Whole Food

    Are the apparently amazing benefits of amla—dried Indian gooseberries—too good to be true? In reference to amla, also known as the Indian gooseberry, it’s been said that “medicinal plants are nature’s gift to human beings to promote a disease free healthy life.” The fruit has also been described as “the Ayurvedic wonder.” You hear a […]

  • Masks at the Campfire: Summer Camps for Kids With Medical Needs Adapt to Covid

    Olivia Klassen’s face lights up when she talks about summer camp. She loves to do the scavenger hunt with her camp friends. She also loves paddleboarding, swimming in the lake and “kitchen raids.” But what she loves most is being surrounded by kids who, just like her, have Type 1 diabetes — which allows her […]

  • Tackling diabetes & ALS with cell therapy

    Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral sclerosis (ALS) and diabetes. Catherine Longworth spoke with Kadimastem’s head of diabetes research, Kfir Molakandov to find out more. In the 1990s, when the first transplant of islets took place, […]

  • Are prices for diabetes drugs rising or falling?

    Conventional wisdom would hold that the prices are rising…aren’t they? To correctly answer this question, one must define which prices you are talking about. Are we looking at the list price that is widely available or the net price after we take into account discounts are rebates life sciences firms pay? A paper by Sarpatwari […]

  • Novo Nordisk ups forecasts after Q1 profit boost

    After an indifferent period Novo Nordisk has kicked off 2021 on the front foot, raising its financial forecast after posting better than expected Q1 earnings and sales. The world’s biggest manufacturer of diabetes drugs expects growth in constant currencies at between 6% and 10%, up from the previous forecast in the 5%-9% range. Operating profit […]

  • ViewPoints Interview: Zealand Pharma’s Emmanuel Dulac Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

    In an interview with PharmaShots, Emmanuel Dulac, Pharm.D., Ph.D., President and CEO of Zealand Pharma shares insight on the US FDA’s approval of Zegalogue and its availability in both an auto-injector and a prefilled syringe in June 2021. He also highlighted the importance of approval for the company and patients with hypoglycemia.   Shots: The approval […]

  • Keto-based digital diabetes program nets $133M  

    Virta Health, a digital health startup with an app-based coaching program for type 2 diabetes, raised $133 million led by Tiger Global. Unlike other digital health companies, Virta builds its program around a ketogenic diet.

  • Virta Health Raises $133M to Expand Type 2 Diabetes Reversal Platform

    What You Should Know: – Virta Health, a San Francisco, CA-based company raises $133M led by , to scale its virtual metabolic clinic and approach to reversing chronic metabolic conditions (type 2 diabetes, prediabetes, and obesity) to the masses led by Tiger Global. – The Series E financing follows a recent $65 million raise in […]

  • Should You Get an Annual Health Check-Up?

    What are the risks and benefits of getting an annual check-up from your doctor? Physicians and patients have come to expect the annual check-up as a routine part of care. “However, considerable research has not demonstrated a substantial benefit,” so a “revolt is brewing against the tradition of periodic” check-ups. “Even the Society for General […]

  • Roche and Biocorp Launch Mallya Smart Insulin Pen for Patients with Diabetes in France

    Shots: The companies launched the Mallya smart insulin pen device in France to support patients with diabetes. The smart insulin pen is available in pharmacies and is compatible with any disposable insulin pens The device collects and transfers insulin data with 100% accuracy and is rechargeable via its USB port. Mallya automatically collects insulin data […]

  • Readers and Tweeters Give Tips on Treating Diabetes and Long Covid

    Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Glucose Monitors Can Benefit All Types I disagree with the negative tone of a recent KHN article about whether continuous glucose monitoring (CGM) helps non-insulin-using people with Type 2 diabetes (Type […]

  • Blue Shield of CA Expands into Digital Health with Wellvolution Expansion

    What You Should Know: – Blue Shield of California is enhancing its popular Wellvolution program by adding two new services that provide personalized care and nutrition support for members living with or at risk for Type 2 diabetes. – Wellvolution is a digitally based lifestyle medicine and health platform that can be personalized to each […]

  • COVID Exposed The Dire Need for Real-Time Healthcare Data Sharing

    Birju Shah, Head of Product for Uber Health & Communities Nick Jordan, Founder and CEO, Narrative In a world where technology and Big Data can provide us with instantaneous access to our banking transactions, and our financial information and credit reports can be retrieved with a few keystrokes when applying for a mortgage — trying to […]

  • Top 5 Recipes for Diabetes: How to Maintain Healthy Diet in Diabetic People?

    When it comes to Diabetes, there are atleast dozens of different advices you can expect from different people. Don’t eat sweets, carbs are bad for you, dessert is a big no, etc. are some of the most common advices people often gives. But, what’s dangerous and not healthy is give a heed to these advices […]

  • Can Diabetes be Reversed by Following Diet & Healthy Lifestyle?

    When it comes to reversing diabetes, let’s clear that out that its Diabetes Type 2 that is reversible and not Type 1. But what makes us all wonder is If Diabetes Type 2 really reversible? Or it’s just a myth or saying? The truth is even though there is no cure for diabetes, Type 2 […]

  • How the Pandemic is Accelerating the Shift to Alternative Care Delivery Models

    Mark Prather MD, MBA, CEO & Co-founder at DispatchHealth The COVID-19 pandemic has transformed how we interact with one another, with businesses, and with the world around us. From social distancing to hand sanitation to remote working, its impact on society is immense. And among the various industries that are experiencing significant change as a […]

  • Cloud Technologies in Healthcare: Improving Access to Care at Lower Costs

     Venky Ananth, SVP, Global Head of Healthcare at Infosys The healthcare industry has been among those at the fore when it comes to cloud adoption. It’s no wonder then that between 2020 and 2024, the global market is projected to see a rise of nearly US$25.54 billion in cloud technologies in this industry1. What has […]

  • Glooko Raises $30M to Expand Digital Diabetes Management Platform

    What You Should Know: – Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, […]

  • Benefits of Turmeric for Arsenic Exposure

    What happened when turmeric curcumin was put to the test to see if it could reverse DNA damage caused by arsenic exposure? Arsenic is a carcinogenic heavy metal, and the major mechanism of arsenic-related damage appears to be oxidative stress. It’s the arsenic-induced accumulation of free radicals that can kill off cells and damage our […]

  • How to Avoid Lectin Poisoning

    How should we properly cook beans? In the 1800s, a compound was discovered in castor beans, which we would come to know as the first of a class of lectin proteins, natural compounds found throughout the food supply, but concentrated in beans, whole grains, and certain fruits and vegetables. Every decade or two, a question […]

  • Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes

    Shots: Biolojic to receive ~$121M including development and commercialization milestones and a promissory note that may be convertible into Biolojic equity in future Additionally, Biolojic is eligible to receive royalties on sales of therapies that emerges during the collaboration The collaboration will leverage Biolojic’s AI-based multibody platform to discover and develop a potential novel Ab-based […]

  • Innovative, Non-Invasive Technologies Advanced Earlier Detection & Monitoring of Liver Disease

    Jon Gingrich, CEO, Echosens North America Leveraging technological advances to facilitate new ways of engaging patients and integrating non-invasive technology into a liver disease program not only serves to improve individual outcomes and reduce costs but also strengthens the financial performance of health systems and provider organizations that include this approach to testing. At a […]

  • Dr. Gundry’s The Plant Paradox Is Wrong

    A book purported to expose “hidden dangers” in healthy foods doesn’t even pass the whiff test. I started getting emails about The Plant Paradox, a book purporting to expose “the hidden dangers in ‘healthy’ foods that cause disease and weight gain”—foods like beans, whole grains, and tomatoes. Hidden dangers? The author’s talking about lectins in […]

  • Data-Driven Future: Impact of Machine Learning on Diabetes Management

    Athar Siddiqui:  Global Strategy Lead, Digital Connected Solutions –  Ascensia Diabetes Care “Information technology and business are becoming inextricably interwoven. I don’t think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.  […]

  • Verily’s Onduo Virtual Care Solution Expands to Multi-Condition Platform

    What You Should Know: – Verily’s Onduo, known for its tech-based solution for virtual diabetes management, is launching a new multi-condition platform that matches the right care to the right consumer at the right time. The expanded virtual care platform is designed to support patients managing type 2 diabetes and hypertension, with plans for further expansion into mental […]

  • The Combination of 5G and AI Will Transform Healthcare in 2021

    Bryan Lubel, Executive Vice President, Connected Health of KORE Not many will disagree that the global pandemic has accelerated the use of technology in healthcare. With a healthcare system stressed to a breaking point, medical professionals have had to prioritize critical cases and increasingly turn to technology tools such as telemedicine and remote patient monitoring […]

  • DarioHealth Acquires Musculoskeletal Solution Upright for $31M

    What You Should Know: – DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on driving behavior change rather than treating the acute problem. This move will more than double revenue and create one of the largest integrated digital health companies in the space. In […]

  • Readers and Tweeters Fight Stigma and Salute Front-Line Workers

    Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. In case you need your blood to boil, read this story about a woman’s surprise medical bill for lab tests she never requested and was never informed would happen. #health #healthcare […]

  • New insulin report highlights how incentives benefit middlemen, harm patients

    The Senate Finance Committee has released a new report detailing findings of their investigation into the role that market dynamics play in the pricing of insulins. The report conclusions further solidify what we already know: perverse incentives in the market drove up insulin costs for patients. Some key details. Many insulins have experienced significant net […]

  • Do the Pros of Brown Rice Outweigh the Cons of Arsenic?

    Are there unique benefits to brown rice that would justify keeping it in our diet despite the arsenic content? For years, warnings had been given about the arsenic levels in U.S. rice potentially increasing cancer risk, but it had never been put to the test until a study out of Harvard. The finding? “Long-term consumption […]

  • Cerner Leadership Changes, Other Key Executives Hires

    Travis Dalton Dan Devers Cerner announced some leadership changes promoting long-time associates Travis Dalton to Chief Client & Services Officer and Dan Devers to Chief Legal Counsel. After long, respected, meaningful careers at Cerner, John Peterzalek and Randy Sims will be departing. Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with […]

  • FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program

    What You Should Know: – FCC announces initial 14 pilot project selected for $100M Connected Care Pilot Program that will support connected care service across the country and focus on low-income and veteran patients. The Federal Communications Commission (FCC) today announced an initial set of 14 pilot projects with over 150 treatment sites in 11 […]

  • Is White Rice a Yellow-Light or Red-Light Food?

    Arsenic is not just considered to be a carcinogen; it’s also designated as a “nonthreshold carcinogen, meaning that any dose, no matter how small, carries some cancer risk”—so there really isn’t a “safe” level of exposure. Given that, it may be reasonable to “use the conservative ALARA” approach, reducing exposure As Low As Reasonably Achievable. […]

  • Teladoc Health, Dexcom Offers CGM-Powered insights to People with Type 2 Diabetes

    What You Should Know: – Teladoc Health and Dexcom announced an expanded partnership on a new offering measures the impact of continuous glucose monitoring and real-time health recommendations for people with Type 2 diabetes at no cost. Teladoc Health, Inc., the first and only comprehensive virtual care system, and DexCom, Inc., the leader in real-time […]

  • Novo Nordisk’s gene silencing alliance with Dicerna bears first fruit

    Two years after starting to work together, Novo Nordisk and Dicerna have selected the first candidate from a joint project to find new, gene-silencing drugs for liver-related cardiometabolic diseases. Danish drugmaker Novo Nordisk signed a deal with the US biotech in 2019 valued at up to $675.5 million – including $175 million upfront and an […]

  • How to Capitalize on Digital Health Momentum in 2021

    Adam Sabloff, Founder and CEO of VirtualHealth As we re-examine the healthcare system in the wake of the pandemic, we are continually identifying opportunities to rebuild parts of the system to new and improved specifications. One critical facet is digital health, where we continue to struggle with what should really be table stakes: the ability […]

  • Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders

    Donovan Quill, President and CEO, Optime Care Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. […]

  • Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population

    What You Should Know: –  Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. – Vida’s diabetes management program achieves lasting results for participants. Because chronic conditions like diabetes, obesity, and hypertension often occur simultaneously, Vida’s unique program was built from the ground up to […]

  • Digital Diabetes Market to Reach $1.5B by 2024, Research Finds

    What You Should Know: – The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. – The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics […]

  • Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health

    What You Should Know: – Cerner Corporation today announced with Xealth new centralized digital ordering and monitoring for health systems, starting with Banner Health, to foster digital innovation. – Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address areas such as chronic disease management, behavioral health, maternity care, […]

  • Elation Health Nabs $40M for Clinical-First Solution to Power Independent Primary Care

    What You Should Know: – Elation Health, which provides an easy-to-use and affordable clinical technology platform for more than 7 million independent primary care clinicians serving 14M+ patients – including an EHR raises $40M in Series C funding from Al Gore’s sustainable investment firm, Generation Investment Management. – Elation’s API-enabled platform also allows organizations to […]

  • Lilly surges on positive phase 3 readout from diabetes contender

    Eli Lilly’s decision to throw large amounts of research dollars at its next-generation diabetes drug tirzepatide could be vindicated, according to its first phase 3 trial readout. Results from the phase 3 SURPASS trial showed tirzepatide led to a reduction in both blood sugar and body weight in adults with type 2 disease, compared with […]

  • Cancer Risk from Arsenic in Rice and Seaweed

    A daily half-cup of cooked rice may carry a hundred times the acceptable cancer risk of arsenic. What about seaweed from the coast of Maine? “At one point during the reign of King Cotton, farmers in the south central United States controlled boll weevils with arsenic-based pesticides, and residual arsenic still contaminates the soil.” Different […]

  • Highmark Taps Lark Health for AI-Driven Chronic Disease Management/Prevention

    What You Should Know: – Highmark, one of the largest Blues plans, has chosen Lark Health for its chronic disease prevention and management platform. – Members will have access to Lark’s 24/7 AI-based coaching and programs to manage diabetes, hypertension, and prevent chronic conditions. Highmark Inc., America’s fourth-largest overall Blue Cross Blue Shield-affiliated organization, announced […]

  • Highmark, Lark Health extend collaboration

    The expanded partnership increases the number of Highmark health plan members eligible for enrollment in Lark Health’s AI-driven health coaching programs aimed at managing and preventing chronic diseases.

  • Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

    Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology sustains performance for ~14days, providing trends, insights & actionable data […]

  • The Effects of Too Much Arsenic in the Diet

    Even at low-level exposure, arsenic is not just a class I carcinogen, but may also impair our immune function and increase our risk of cardiovascular disease and diabetes. When people hear about arsenic, they think of it as an acute poison, and, indeed, a tiny amount—a hundred milligrams, about one-tenth the weight of a paperclip—could […]

  • First results of the DiabetRisk study

    First results of the DiabetRisk study – Over 8% of patients identified with undiagnosed diabetes or pre-diabetes at dental practices The DiabetRisk study could contribute to early diagnosis of diabetes in thousands of dental patients each year – and in every country worldwide Simple screening process applied to 1,143 dental patients at 41 dental practices […]

  • How Care Coordination Technology Addresses Social Isolation in Seniors

    Jenifer Leaf Jaeger, MD, MPH, Senior Medical Director, HealthEC Senior isolation is a health risk that affects at least a quarter of seniors over 65. It has become recognized over the past decade as a risk factor for poor aging outcomes including cognitive decline, depression, anxiety, Alzheimer’s disease, obesity, hypertension, heart disease, impaired immune function, […]

  • Helixmith starts new trial of diabetic neuropathy gene therapy

    Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study. The South Korean biotech says the DNA plasmid-based therapy has been administered to a patient at Innovative Research of West Florida. The aim is […]

  • Towards a new understanding of cardiovascular risk in diabetes

    A new post-hoc analysis from Novo Nordisk of their SUSTAIN 6 and PIONEER 6 studies into semaglutide is looking to help ‘individualise’ treatment for diabetes patients by better predicting their cardiovascular lifetime risk. We spoke to lead study investigator, Utrecht University’s Dr Jan Westerink, to find out how he sees the results being used in […]

  • Intermountain Adds Omada’s Diabetes Prevention Program to At-Risk Patients

    What You Should Know: – Omada’s diabetes prevention program will be available to Intermountain’s at-risk patient population as part of a limited engagement in 2020 and 2021. – Omada’s diabetes prevention program is personalized to meet each participant’s unique needs as they evolve, ranging from diabetes prevention, type 2 diabetes management, hypertension, behavioral health, and […]

  • Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

    Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020 The integrated system provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes through a single smartphone app InPen is the […]

  • Pharma’s response to COVID: Lilly and diabetes care

    As part of our series looking at how pharma companies have adapted to the pandemic, Shannon Rush, leader of Eli Lilly & Co’s diabetes business unit in Northern Europe, tells pharmaphorum how the company is working to support diabetes care in the UK amid the pandemic. As COVID-19 turned the world on its head, healthcare […]

  • Novo Nordisk to buy Emisphere and diabetes pill tech for $1.8bn

    Novo Nordisk has agreed to buy Emisphere Technologies for $1.8 billion, as it continues its quest to develop diabetes medicines that can be taken as pills. Copenhagen-based Novo Nordisk already markets Rybelsus (semaglutide), a version of its GLP-1 class drug that can help to control blood sugar levels in patients with type 2 disease. But […]

  • 4 Ways to Combat Hidden Costs Associated with Delayed Patient Care During COVID-19

    Matt Dickson, VP, Product, Strategy, and Communication Solutions at Stericycle COVID-19 terms such as quarantine, flatten the curve, social distance, and personal protective equipment (PPE) have dominated headlines in recent months, but what hasn’t been discussed in length are the hidden costs of COVID-19 as it relates to patient adherence.   The coronavirus pandemic has amplified […]

  • How RPA Can Help Get COVID-19 Vaccines to High-Risk Patients First

    Ram Sathia, VP of Intelligent Automation at PK While most of the public’s attention is focused on the horse race for an approved COVID-19 vaccine, another major hurdle lies just around the corner: the distribution of hundreds of millions of vaccine doses. In today’s highly complex and disconnected health data landscape, technologies like AI, Machine […]

  • Lark Health raises $70M

    Lark Health, which offers AI-powered digital care platforms for chronic diseases, has raised $70 million in new funds, which it plans to use to expand its relationship with Anthem and eventually deepen partnerships with other payers and telehealth providers.

  • What White Blood Cell Count Should We Shoot for?

    At the start of my video What Does a Low White Blood Cell Count Mean?, you can see what it looks like when you take a drop of blood, smear it between two pieces of glass, and view at it under a microscope: a whole bunch of little, round, red blood cells and a few […]

  • CareLinx, Doctor on Demand Partner to Bring In-Home Virtual Care to Seniors

    What You Should Know:  – Doctor On Demand and CareLinx, one of the largest professional networks for in-home care, have announced a collaboration to bring in-home virtual care services to CareLinx clients.  – At a time when seniors have been encouraged to stay home to avoid exposure to COVID, Doctor On Demand’s partnership with CareLinx […]

  • Rural Hospital Execs Can Beat COVID-19 By Shifting From Reactive to Proactive Care

    Eric Tran, Tulane School of Medicine Donald Voltz, MD, Aultman Hospital The COVID-19 virus is ravaging the planet at a scale not seen since the infamous Spanish Flu of the early 1900s, inflicting immense devastation as the U.S. loses more than 200,000 lives and counting. According to CDC statistics, 94% of patient mortalities associated with […]

  • Priority Health Launches Telehealth PCP Plans for Members in Michigan

    What You Should Know: – Priority Health launches its virtual-first coverage option with MyPriority Telehealth PCP plans, using top platform Doctor On Demand. – Members who choose one of the MyPriority Telehealth PCP plans will have a doctor assigned as their primary care physician (PCP) through Doctor on Demand and all visits will take place […]

  • FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

    What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing the next generation of digital medicine, today announced its EaseVRx […]

  • Blue Cross NC Launches No-Cost Virtual Programs to Quit Smoking and Reverse Diabetes

    What You Should Know: – Today, Blue Cross and Blue Shield of North Carolina partners with Carrot Inc. and Virta Health to help address two of the largest ongoing health issues facing Americans today – smoking and type 2 diabetes. – Virta and Carrot’s programs will be available to individual under-65 members and fully insured […]

  • Progressive Group Highlights Trump, Tillis Weakness on Insulin Price Tags

        During the first presidential debate of 2020, President Donald Trump touted his efforts to curb skyrocketing drug prices and declared that insulin is now “so cheap, it’s like water.” The response on social media was swift, and divided, with some people sharing pharmacy bills showing thousands of dollars they’d spent on insulin, while […]

  • Eli Lilly Collaborates with Dexcom for Diabetes Management

    Shots: The companies will partner to promote Lyumjev (insulin lispro-aabc injection, 100 & 200 units/mL) with Dexcom G6 CGM to aid HCPs in the US for the management of diabetes, including giving visibility to the benefits of a new mealtime insulin HCPs treating T1D & T2D will be able to assess their patient’s glucose levels […]

  • Virta Expands Offerings to Treat New Group of Chronic Illnesses

    What You Should Know: – Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. – By making this crucial expansion, Virta can scale its treatment to support the tens of millions of additional patients with prediabetes and obesity, as provide an on-ramp to reversal for […]

  • Not Pandemic-Proof: Insulin Copay Caps Fall Short, Fueling Underground Exchanges

    DENVER — D.j. Mattern had her Type 1 diabetes under control until COVID’s economic upheaval cost her husband his hotel maintenance job and their health coverage. The 42-year-old Denver woman suddenly faced insulin’s exorbitant list price — anywhere from $125 to $450 per vial — just as their household income shrank. She scrounged extra insulin […]

  • NIH Funds First Nationwide Rare and Atypical Diabetes Network

    What You Should Know: – NIH awards funding for Rare and Atypical Diabetes Network, or RADIANT that will seek to discover the cause of several unusual forms of diabetes. – RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that do not fit the common features of type 1 and […]

  • Accounting for the Social Determinants of Health During the COVID-19 Pandemic

    Andy Aroditis, CEO, NextGate The COVID-19 pandemic is not just a medical crisis.  Since the highly contagious disease hit American shores in early 2020, the virus has dramatically changed all sectors of society, negatively impacting everything from food supply chains and sporting events to the nation’s mental and behavioral health. For some people, work-from-home plans […]

  • Why Hasn’t A More Holistic Approach to Patient Care Become The Norm?

    When food production technology made it possible, wheat flour processors started to eliminate the tough exterior (bran) and nutrient-rich core (germ) of the kernel to get at the large, starchy part (the endosperm) only. The bread produced from this process is white and fluffy, and it makes great PB&Js and takes forever to grow mold, […]

  • Sharing rebates can improve access to medicines and increase health equity

    Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Today, we are pleased to welcome a guest post from Dr. Leah […]

  • Validic Launches New Remote Patient Monitoring Solution, Requires No EHR Integration

    What You Should Know: – Validic launches the newest version of its remote patient monitoring (RPM) offerings, Validic Impact: Rapid Deployment. – This new standalone version of Validic Impact requires no EHR integration and can be used as a fully standalone solution. Validic, a Durham, NC-based provider of health data platforms and solutions for scaling […]

  • The Coronavirus Crisis’ Silent Death Toll: Chronically Ill Patients

    Dr. Kayur Patel, Chief Medical Officer of Proactive MD The impact of the coronavirus crisis is shining a bright light on many of the challenges facing the U.S. healthcare system.  So much more than a lack of primary care physicians and hospital beds, the all-hands-on-deck approach to combating the spread of COVID-19 has forced patients […]

  • Sensyne Health launches diabetes app in the UK

    UK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes spectrum manage their condition. The app – called DBm-Health – can help users to monitor their blood glucose levels and send readings, notes and medication information to their healthcare practitioner to assess remotely. It is a follow-on […]

  • 4 Ways Businesses Will Adapt Their Healthcare Landscape

    Dr. Donald Brown, CEO and founder of LifeOmic The coronavirus pandemic has affected every aspect of our lives, from how we work to how we get our health care. The crisis has put the creativity of many small businesses to the test after being forced to move operations online once social distancing became the norm. […]

  • Medtronic Acquires Smart Insulin Pen Company Companion Medical

    What You Should Know: – Today, Medtronic announced that it will acquire Companion Medical, the manufacturer of InPen, a smart insulin pen system paired with an integrated diabetes management app. – The addition of Companion’s InPen system builds upon Medtronic’s strategic acquisitions of Nutrino and Klue to further improve overall automated decision-making capabilities and optimizes dosing decisions using […]

  • $5M Research Grant Launches to Evaluate Efficacy of Virtual Diabetes Care

    What You Should Know: – DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a $5 million grant from The Leona M. and Harry B. […]

  • Novo Nordisk beats Q2 profit forecasts by cutting costs

    Denmark’s Novo Nordisk has beaten profit forecasts in the second quarter after overcoming tough conditions in the diabetes market by improving its productivity. Novo said that COVID-19 has begun to affect sales, with fewer new starts as a result of social distancing measures. The company’s diabetes care products saw an increase in sales during the […]

  • Innovaccer, CareSignal Partner to Enable Deviceless Remote Patient Monitoring

    What You Should Know: – Innovaccer has recently partnered with CareSignal to address healthcare’s urgent need amidst the COVID-19 pandemic: to create and maintain solid, clinically actionable relationships with patients in a new set of predominantly virtual care. – CareSignal offers evidence-based end-to-end support services for chronic medical conditions such as asthma, CHF, COPD, diabetes, […]

  • Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform

    – Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services being offered to patients. – To date, the company has treated more than a million patients online for a variety of medical conditions ranging from erectile dysfunction to sinus infections to […]

  • The Adoption of Telehealth During the Pandemic will Shape Healthcare’s New Normal

    Abhinav Shashank, CEO and Co-founder of Innovaccer Inc. COVID-19 has presented healthcare with a challenge like no other, with nearly nine million cases all over the world and over 470,000 lives lost. The speed of the outbreak and the disruption caused by it has created unforeseen challenges for communities and economies, and it’s especially apparent in […]

  • Eli Lilly Reports Results of Jardiance (empagliflozin) in P-III EMPEROR Trial for Heart Failure Patients with Reduced Ejection Fraction with and without Diabetes

    Shots: The P-III EMPEROR Trial involves assessing of Jardiance (10 mg) vs PBO in two studies EMPEROR-Reduced [NCT03057977, N=3,730] & EMPEROR-Preserved [NCT03057951, N=5,990] in patients with HFrEF & HFpEF respectively The EMPEROR-Reduced study meets its 1EPs in reducing the risk for the composite of cardiovascular death or hospitalization due to heart failure while the overall […]

  • What Exercise Authorities Don’t Tell You About Optimal Duration

    Physical fitness authorities seem to have fallen into the same trap as the nutrition authorities, recommending what they think may be achievable, rather than simply informing us of what the science says and letting us make up our own minds. Researchers who accept grants from The Coca-Cola Company may call physical inactivity “the biggest public […]

  • Indigo raises 38 million euros for ‘invisible’ diabetes glucose sensor

    Medical device company Indigo Diabetes has raised 38 million euros to develop an “invisible” sensor for people with diabetes, which could provide an alternative to the “patch” based monitors currently on the market. The new investment round will enable Indigo to prepare and start up the clinical study phase for the device. Indigo hopes that the […]

  • Trial shows AZ’s Farxiga slows onset of chronic kidney disease and cuts mortality

    AstraZeneca’s Farxiga could be on course for another use, after trial results showed it slowed the worsening of renal function and cut the risk of death in patients with chronic kidney disease with and without type 2 diabetes. Farxiga (dapagliflozin), an oral once-daily sodium-glucose co-transporter-2 (SGLT2) inhibitor, started life as a diabetes drug but AZ has […]

  • Current Health, Dexcom Partner to Deliver Continuous, Remote Glucose Monitoring

    What You Should Know: – Current Health has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM) platform – enhancing care and improving outcomes for diabetics. – Dexcom CGM data will transmit directly into the Current Health wearable and platform for review by the care management and clinical […]

  • GoodRx Expands Telehealth Service Nationwide Across All 50 States

    What You Should Know: – GoodRx today announced it has expanded the reach of HeyDoctor by GoodRx and it is now available across all 50 states and Washington D.C. – HeyDoctor provides affordable access to online medical visits from US-licensed providers to treat a wide range of conditions — regardless of insurance status. Treatment and […]

  • Biocon annouces digital diabetes tie-up with Voluntis

    Biocon has announced a deal with digital therapy specialist Voluntis, aiming to create personalised care for people with type 2 diabetes taking biosimilar insulins. The licensing agreement will allow Biocon to offer patients taking insulin an FDA-approved app called Insulia that provides automated insulin dose recommendations allowing people with diabetes to self-manage their condition. It […]

  • What Happens if You Have Red Wine or Avocados with a Meal?

    Whole plant sources of sugar and fat can ameliorate some of the postprandial (after meal) inflammation caused by the consumption of refined carbohydrates and meat. Studies have shown how adding even steamed skinless chicken breast can exacerbate the insulin spike from white rice, but fish may be worse. At 0:18 in my video The Effects […]

  • New CVS Pharmacy App Feature Can Read Prescription Labels Out Loud for Visually Impaired

    What You Should Know: – CVS introduced Spoken Rx™, a new feature of the CVS Pharmacy app that can read important prescription information out loud. It is vitally important for patient safety and adherence that prescription labels are clear and visible, but for patients with visual impairments or those who can’t read standard print labels, that’s not […]

  • Philips and BioIntelliSense Integrate to Enhance Remote Patient Monitoring

    What You Should Know: – Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the hospital. – Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19. – Healthcare Highways is the first to leverage […]

  • Are the BPA-Free Plastics Like Tritan Safe?

    Do BPA-free plastics such as Tritan, have human hormone-disrupting effects? And what about BPS and BPF? Recent human studies indicate that exposure to the plastics chemical BPA may be associated with infertility, miscarriage, premature delivery, reduced male sexual function, polycystic ovaries, altered thyroid and immune function, diabetes, heart disease, and more. Yet, “[a]s recently as […]

  • One Way to Treat Asthma and Autoimmune Diseases with Diet

    Cutting two teaspoons of salt’s worth of sodium from one’s daily diet can significantly improve lung function in asthmatics In the 1960s and 1970s, a mystery was emerging. Why were childhood asthma rates between 2 to 5 percent in the developed world but as low as 0.007 percent in the developing world? For example, in […]

  • How to Foster a Healthy Gut Flora

    What’s more important: probiotics or prebiotics? And where can we best get them? “Virtually every day we are all confronted with the activity of our intestine, and it is no surprise that at least some of us have developed a fascination for our intestinal condition and its relation to health and disease.” “Over the last […]

  • How to Prevent the Infection that May Trigger Type 1 Diabetes

    The compelling finding of Mycobacterium avium paratuberculosis (MAP) circulating disproportionately within the bloodstream of type 1 diabetics was subsequently confirmed by culturing it straight out of their blood. MAP infection and type 1 diabetes appear to go together, but we didn’t know which came first. Does the infection make kids more susceptible to diabetes? Might […]

  • The Role of Meat and Dairy in Triggering Type 1 Diabetes

    Type 1 diabetes “arises following the autoimmune destruction of the insulin-producing pancreatic β [beta] cells…[and] is most often diagnosed in children and adolescents, usually presenting with a classic trio of symptoms” as their blood sugars spike: excessive thirst, hunger, and urination. They need to go on insulin for the rest of their lives, since their […]